Further experience in the use of ancrod (Arvin) to prevent thrombosis on prosthetic heart valves
AUTOR(ES)
Singh, M. P.
RESUMO
Intravenous administration of ancrod produces hypofibrinogenaemia, which may be prolonged by further doses. Hypofibrinogenaemia, maintained for a week, was used to prevent thrombosis on prosthetic heart valves in the calf.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1019121Documentos Relacionados
- The use of ancrod to prevent thrombosis on prosthetic heart valves: An experimental study
- Fibrinolytic treatment of thrombus on prosthetic heart valves.
- Effect of a fibrinolytic agent (Arvin) on wound healing and collagen formation.
- Further observations on the structure of human heart-valves
- The epidemiology of prosthetic heart valves in the United States.
